Tech Company Financing Transactions
uMed Funding Round
On 7/6/2023, uMed raised $12.7 million in Series A funding from 11.2 Capital, AlbionVC and Delin Ventures.
Transaction Overview
Company Name
Announced On
7/6/2023
Transaction Type
Venture Equity
Amount
$12,705,000
Round
Series A
Proceeds Purpose
This New funding round that is aimed directly at combatting staggering NHS statistics that have seen patient access to industry clinical trials nearly fall off a cliff. The company reports that in addition to ramping up UK-focused efforts, a portion of the funding will be used to expand its presence in North America.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
101 6th Avenue, 3rd Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Undisclosed
Website
Email Address
Overview
uMed is a technology enabling a global network of healthcare professionals and patients to participate in highly relevant clinical and real-world research. On behalf of our provider network, we enable researchers to rapidly find the right patients, engage them into a study, and collect prospective data to answer key clinical questions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matt Wilson
Chief Technical Officer
Chris Broderick
Browse more venture capital transactions:
Prev: 7/6/2023: Optiversal venture capital transaction
Next: 7/6/2023: ChipFlow venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs